BRCA1 and cancer: Notably, identifying who should be offered a cancer genetic testing in the Asian community remains challenging as the currently available guidelines for testing have been shown to omit at least 20% of patients carrying BRCA mutations from being tested [21], suggesting the testing criteria on BRCA1 and BRCA2 germline mutations which have been well established in the Caucasian population were not readily applicable to the Asian population.